Outcomes of multidrug-resistant tuberculosis treatment in HIV-positive patients in New York City, 1990-1997.
Frieden
Thomas R
TR
Munsiff
Sonal S
SS
Ahuja
Shama Desai
SD
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D002207:Capreomycin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004333:Drug Administration Routes; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008826:Microbial Sensitivity Tests; D009519:New York City; D012293:Rifampin / Q000627:therapeutic use; D013997:Time Factors; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery
D000904:Antibiotics, Antitubercular; D002207:Capreomycin; D007538:Isoniazid; D012293:Rifampin